Article Text

Download PDFPDF

Proactive community case management and child survival in periurban Mali
  1. Ari D Johnson1,2,
  2. Oumar Thiero3,4,
  3. Caroline Whidden2,
  4. Belco Poudiougou2,
  5. Djoumé Diakité2,
  6. Fousséni Traoré2,
  7. Salif Samaké5,
  8. Diakalia Koné5,
  9. Ibrahim Cissé5,
  10. Kassoum Kayentao2,4
  1. 1 Department of Medicine, University of California, San Francisco, School of Medicine, San Francisco, California, USA
  2. 2 Muso, Bamako, Mali, San Francisco, California, USA
  3. 3 Tulane University, School of Public Health and Tropical Medicine, New Orleans, Louisiana, USA
  4. 4 Malaria Research and Training Centre, Faculty of Medicine and Odontostomatology, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali
  5. 5 Ministry of Public Health and Hygiene, Bamako, Mali
  1. Correspondence to Dr Ari D Johnson; ari.johnson{at}ucsf.edu

Abstract

The majority of the world’s population lives in urban areas, and regions with the highest under-five mortality rates are urbanising rapidly. This 7-year interrupted time series study measured early access to care and under-five mortality over the course of a proactive community case management (ProCCM) intervention in periurban Mali. Using a cluster-based, population-weighted sampling methodology, we conducted independent cross-sectional household surveys at baseline and at 12, 24, 36, 48, 60, 72 and 84 months later in the intervention area. The ProCCM intervention had five key components: (1) active case detection by community health workers (CHWs), (2) CHW doorstep care, (3) monthly dedicated supervision for CHWs, (4) removal of user fees and (5) primary care infrastructure improvements and staff capacity building. Under-five mortality rate was calculated using a Cox proportional hazard survival regression. We measured the percentage of children initiating effective antimalarial treatment within 24 hours of symptom onset and the percentage of children reported to be febrile within the previous 2 weeks. During the intervention, the rate of early effective antimalarial treatment of children 0–59 months more than doubled, from 14.7% in 2008 to 35.3% in 2015 (OR 3.198, P<0.0001). The prevalence of febrile illness among children under 5 years declined after 7 years of the intervention from 39.7% at baseline to 22.6% in 2015 (OR 0.448, P<0.0001). Communities where ProCCM was implemented have achieved an under-five mortality rate at or below 28/1000 for the past 6 years. In 2015, under-five mortality was 7/1000 (HR 0.039, P<0.0001). Further research is needed to elucidate the mechanisms of action and generalizability of ProCCM.

  • child health
  • health services research
  • health systems
  • health systems evaluation
  • public health

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

View Full Text

Statistics from Altmetric.com

Footnotes

  • Handling editor Seye Abimbola

  • Contributors ADJ, DD and FT were involved in the design of the study. KK, BP, DD, FT and IC led the data collection. OT led data cleaning and data analysis. ADJ, CW and OT wrote the manuscript. All authors provided input in the revision and final approval of the manuscript and met the ICMJE authorship conditions.

  • Funding Funds from the Child Relief International Foundation supported this research.

  • Competing interests None declared.

  • Patient consent Participant/guardian consent obtained.

  • Ethics approval This study was reviewed and approved by the ethical committee of the Faculty of Medicine and Odontostomatology of the University of Bamako, Mali, reference 2016/40/CE/FMPOS. The study was also reviewed by the University of California, San Francisco, Human Research Protection Program Committee on Human Research and approved via exempt certification as posing minimal risk to the population being studied, reference nos 10-02198, 004193 and 070270.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data sharing statement The anonymised data sets used for this analysis are available upon request with the corresponding author. If the reader requires any further information, they are welcome to contact the corresponding author.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.